Health Headlines 4/14/06
High Cholesterol Linked To Raised Prostate Cancer Risk ~ Click here.
Appetite-inducing Hormone Receptor Found Active In Breast Cancer ~ Click here.
Long Island Newsday Examines Reports Of Birth Control Patch's Side Effects ~ Click here.
A Jekyll And Hyde Of Cytokines: IL-25 Both Promotes And Limits Inflammatory Diseases ~ Click here.
Shock Wave Therapy For Kidney Stones Linked To Increased Risk Of Diabetes, Hypertension ~ Click here.
New Risks Identified After Early Breast Cancer ~ Click here.
Scientists Discover New Genetic Subtypes Of Common Blood Cancer ~ Click here.
Type Of Breast Cancer Tumor More Important In Determining Treatment Than Tumor Size, Study Says ~ Click here.
Single-Dose Carboplatin Comparable To Prophylactic Radiotherapy For Stage I Seminoma: Results Of A Randomized Trial ~ Click here.
NICE One Step Closer To A Fairer Deal For Prostate Cancer Patients - Men To Benefit From Equality Of Access To Chemotherapy Treatment ~ Click here.
MedImmune Begins Dosing Of Lupus Patients In Phase 1 Clinical Trial ~ Click here.
Appetite-inducing Hormone Receptor Found Active In Breast Cancer ~ Click here.
Long Island Newsday Examines Reports Of Birth Control Patch's Side Effects ~ Click here.
A Jekyll And Hyde Of Cytokines: IL-25 Both Promotes And Limits Inflammatory Diseases ~ Click here.
Shock Wave Therapy For Kidney Stones Linked To Increased Risk Of Diabetes, Hypertension ~ Click here.
New Risks Identified After Early Breast Cancer ~ Click here.
Scientists Discover New Genetic Subtypes Of Common Blood Cancer ~ Click here.
Type Of Breast Cancer Tumor More Important In Determining Treatment Than Tumor Size, Study Says ~ Click here.
Single-Dose Carboplatin Comparable To Prophylactic Radiotherapy For Stage I Seminoma: Results Of A Randomized Trial ~ Click here.
NICE One Step Closer To A Fairer Deal For Prostate Cancer Patients - Men To Benefit From Equality Of Access To Chemotherapy Treatment ~ Click here.
MedImmune Begins Dosing Of Lupus Patients In Phase 1 Clinical Trial ~ Click here.
0 Comments:
Post a Comment
<< Home